Karina Abarca-Cascante
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karina Abarca-Cascante has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Bryan Zúñiga-Gaitán
Universidad Nacional
1 shared publication - Jorengeth Abad Rodríguez-Rodríguez
Microbial Biotechnology Laboratory, School of Biological Sciences, Universidad Nacional, Heredia 83-3000, Costa Rica
1 shared publication - José Bernal Azofeifa-Bolaños
Universidad Nacional
1 shared publication - Judith Cambronero Vega
Universidad Nacional
1 shared publication - Nicole Arias Espinoza
Advanced Computing Laboratory, National Center of High Technology,San Jos,Costa Rica
1 shared publication - Víctor Álvarez-Valverde
Phytochemistry Laboratory (LAFIT), School of chemistry, Universidad Nacional (UNA), Costa Rica
1 shared publication
Latest Publications
- Open Access
- 9 September 2024
- Published by Instituto Tecnologico de Costa Rica in Revista Tecnología en Marcha
- Vol. 37, ág 68-74
Evaluation of the antimicrobial properties of natural extracts of Ganoderma lucidum
There is a growing importance of alternative anticancer and anti-inflammatory treatments. Current interest lies in natural medicine and secondary metabolites present in plants, particularly focusing on triterpenes. Ganoderma lucidum is a fungal species of significant commercial interest due to its therapeutic and medicinal properties resulting from secondary metabolites such as polysaccharides and triterpenes. These compounds exhibit antitumor activity and bolster the immune system. The study aimed to assess the antimicrobial activity of G. lucidumextracts, both commercial and wild. The content of ganoderic acids in all extracts showed a slight difference in concentration between commercial and wild extracts. However, no bacterial inhibition halos were observed in any of the strains used. The presence of varying concentrations of ganoderic acids among treatments underscores the importance of optimizing and standardizing a comprehensive strategy for extracting secondary metabolites, focusing on producing high-quality supplements and pharmaceutical products. Furthermore, preserving the stability of the obtained triterpenes is necessary due to their importance in the medicinal properties of the fungus.
- 9 September 2024
- Published by Instituto Tecnologico de Costa Rica in Revista Tecnología en Marcha
- Vol. 37, ág 68-74
Open AccessEvaluation of the antimicrobial properties of natural extracts of Ganoderma lucidum
There is a growing importance of alternative anticancer and anti-inflammatory treatments. Current interest lies in natural medicine and secondary metabolites present in plants, particularly focusing on triterpenes. Ganoderma lucidum is a fungal species of significant commercial interest due to its therapeutic and medicinal properties resulting from secondary metabolites such as polysaccharides and triterpenes. These compounds exhibit antitumor activity and bolster the immune system. The study aimed to assess the antimicrobial activity of G. lucidumextracts, both commercial and wild. The content of ganoderic acids in all extracts showed a slight difference in concentration between commercial and wild extracts. However, no bacterial inhibition halos were observed in any of the strains used. The presence of varying concentrations of ganoderic acids among treatments underscores the importance of optimizing and standardizing a comprehensive strategy for extracting secondary metabolites, focusing on producing high-quality supplements and pharmaceutical products. Furthermore, preserving the stability of the obtained triterpenes is necessary due to their importance in the medicinal properties of the fungus.